News
12-17-2013, 02:48 AM
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found.
More... (http://www.medicalnewstoday.com/releases/270166.php)
More... (http://www.medicalnewstoday.com/releases/270166.php)